Background: The COVID-19 pandemic significantly impacted global mortality, underscoring the need for reliable data to guide public health policy. In low- and middle-income countries, graveyard-based death records can offer valuable insights into COVID-19-related mortality, yet they remain limited. Additionally, data on mortality beyond the pandemic remains scarce as we approach the 2030 Sustainable Development Goals. We addressed this gap by using graveyard-based data to assess excess mortality during the pandemic (2020-23) and predict mortality trends through 2030.
Methods: We analysed 70 585 deaths from six graveyards in Dhaka, Bangladesh, from January 2001 to December 2023. The data was divided into pre-COVID-19 (2001-19), peak-COVID-19 (2020-21), and end-of-COVID-19 (2022-23) phases. We assessed the excess mortality using the P-score and Bayesian approach. We estimated excess mortality with a log-linear Bayesian model and predicted death trends for 2024-30, reporting incidence rate ratio (IRR) with 95% credible intervals (CrI).
Results: Overall, excess mortality was 69% greater in 2020 and 31% in 2023 compared to the 2018-19 average. The IRR for deaths during peak-COVID-19 was 1.66 times higher than pre-COVID-19 (95% CrI = 1.35-2.04). Neonates had significantly higher IRRs during both the peak (IRR = 1.45; 95% CrI = 1.02-2.05) and end-of-COVID-19 (IRR = 1.67; 95% CrI = 1.02-2.71). Individuals aged >40 years showed a significantly higher IRR during peak-COVID-19 (IRR = 1.79; 95% CrI = 1.46-2.18). Predictions using data between 2001-23 indicate rising mortality, with the number of adult deaths increasing from 3318 in 2023 to 5089 (95% CrI = 3871-6267) by 2030.
Conclusions: We revealed a significant rise in mortality during the pandemic, with elevated death rates persisting at the end of the pandemic. Predictions indicate continued mortality increases through 2030, underscoring the pandemic's long-term health impacts. While further research is needed, these findings highlight the value of graveyard-based death registration data for tracking mortality trends and informing public health strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869516 | PMC |
http://dx.doi.org/10.7189/jogh.15.04050 | DOI Listing |
J Clin Rheumatol
March 2025
Coordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Puebla, Mexico.
Introduction: Patients with polymyositis and dermatomyositis (PM/DM) are prone to multiple complications that may lead to increased mortality rates. Data about PM/DM mortality in Mexico are lacking.
Objective: The aim of this study was to assess mortality trends in PM/DM in Mexico across 2 decades (2000-2019), overall, by sex, age group, and geographic region.
Clin Transplant
March 2025
Division of Cardiac Surgery, CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA.
Background: This study aims to analyze the patient characteristics, clinical outcomes, and contemporary trends concerning type A aortic dissection (TAAD) in previous recipients of abdominal solid organ transplantation (ASOT) in the United States.
Methods: The National Inpatient Sample was queried to identify all patients aged ≥18 with TAAD and a history of ASOT (TAAD-ASOT) between 2002 and 2015Q3 using ICD-9 diagnosis and procedure codes. Baseline characteristics and in-hospital outcomes were compared between TAAD-ASOT patients and TAAD patients without a history of ASOT (TAAD-non-ASOT).
Pediatr Infect Dis J
March 2025
Department of Pediatrics and Intensive Care Medicine.
Background: To evaluate the disease burden, risk of complications and mortality in children with viral detection during the peri-liver transplant period.
Methods: A retrospective cohort study was conducted between January 2020 and December 2023 at a tertiary university hospital. Children who underwent multiplex polymerase chain reaction testing from 7 days before to 14 days after liver transplantation were included.
J Infect Dis
March 2025
Service de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor - Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), 94010 Créteil, France.
Background: Respiratory syncytial virus (RSV) is one of the deadliest respiratory viruses. There is a need to better identify prognostic factors in RSV-infected patients, particularly those requiring intensive care unit (ICU) admission, with a focus on immunosuppressed patients.
Methods: Multicenter, retrospective cohort study of RSV-infected adults hospitalized in 17 ICUs in the Great Paris area between 08/01/2017 and 05/01/2023.
Am J Public Health
April 2025
Donrie Purcell is with the Satcher Health Leadership Institute, Morehouse School of Medicine (MSM), Atlanta, GA. Wayne A. Duffus is with the Department of Medicine, Division of Infectious Diseases, University of South Carolina School of Medicine, Columbia. Maisha Standifer is with the Satcher Health Leadership Institute and Department of Community Health and Preventive Medicine, MSM. Robert Mayberry is with the Department of Community Health and Preventive Medicine and the MSM Research Design and Biostatistics Core, MSM. Sonja S. Hutchins is with the Department of Community Health and Preventive Medicine, MSM.
To evaluate the impact of the COVID-19 pandemic on HIV mortality rates with a focus on demographic predictors and Medicaid access. Using Wide-Ranging Online Data for Epidemiologic Research, we conducted a descriptive study comparing HIV mortality in the United States 2 years before the COVID-19 pandemic (2018-2019) and the initial 2 years of the pandemic (2020-2021), and identifying HIV mortality factors during the pandemic. During the first 2 years of the pandemic, crude HIV death rates increased and then decreased marginally.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!